Roca Therapeutics develops drugs against diseases favored by hyper-vascularization and immuno-suppressive inflammation
Automatic translation

Technologies

  • REDBIOTECH
  • BIOENGINEERING

Activity area

  • PHARMATECH
  • CLINIC
  • ONCOLOGY
  • BIOTECH

Maturity stage

  • Early bird

Key information

Year of creation

2021

Workforce

< 10

Maturity stage

Early bird